Anna Titova Selected Research

Anna Titova Research Topics

5	Thrombosis (Thrombus) 01/2022 - 01/2016
2	Inflammation (Inflammations) 10/2023 - 01/2018
2	Hemorrhage 01/2022 - 01/2018
2	Myocardial Infarction 01/2018 - 01/2018
1	Necrosis 10/2023
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022
1	COVID-19 01/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021
1	Arteritis 11/2020
1	Stroke (Strokes) 01/2020
1	Lung Injury 01/2018
1	Muscle Cramp (Cramp) 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Pathologic Processes 01/2016
1	Essential Hypertension 11/2012

2	Glycoproteins (Glycoprotein)IBA 01/2022 - 01/2018
1	ChemokinesIBA 10/2023
1	AntibodiesIBA 01/2022
1	Adenovirus VaccinesIBA 01/2022
1	Platelet Factor 4IBA 01/2022
1	Platelet Membrane GlycoproteinsIBA 01/2022
1	ChAdOx1 nCoV-19IBA 01/2022
1	Heparin (Liquaemin)FDA LinkGeneric 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	Interleukin-8 (Interleukin 8)IBA 01/2021
1	Angiotensin IIIBA 11/2020
1	RNA (Ribonucleic Acid)IBA 11/2020
1	danaparoid (Orgaran)FDA Link 01/2020
1	Type C PhospholipasesIBA 01/2018
1	N- alpha- benzoyl- N5- (2- chloro- 1- iminoethyl)- L- ornithine amideIBA 01/2018
1	Blood Coagulation Factors (Coagulation Factor)IBA 01/2018
1	AcidsIBA 01/2018
1	Protein-Arginine DeiminasesIBA 01/2018
1	src-Family KinasesIBA 01/2018
1	CathelicidinsIBA 01/2018
1	FibrinIBA 01/2016
1	Fibrinogen (Factor I)FDA Link 01/2016
1	MetalsIBA 01/2016

2	Catheters 01/2016 - 11/2012
1	Stents 01/2016
1	Percutaneous Coronary Intervention 01/2016
1	Thrombectomy 01/2016
1	Drug-Eluting Stents 01/2016
1	Denervation 11/2012